Enzon Pharmaceuticals Stock Z Score
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Enzon |
Enzon Pharmaceuticals OTC Stock Z Score Analysis
Enzon Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Enzon Pharmaceuticals Z Score | -1.4 |
Most of Enzon Pharmaceuticals' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enzon Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Enzon Pharmaceuticals has a Z Score of -1.4. This is 120.74% lower than that of the Biotechnology sector and 141.92% lower than that of the Health Care industry. The z score for all United States stocks is 116.06% higher than that of the company.
Enzon Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enzon Pharmaceuticals' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Enzon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Enzon Pharmaceuticals by comparing valuation metrics of similar companies.Enzon Pharmaceuticals is currently under evaluation in z score category among its peers.
Enzon Fundamentals
Return On Equity | -0.016 | ||||
Return On Asset | -0.0138 | ||||
Operating Margin | (36.28) % | ||||
Current Valuation | 17.63 M | ||||
Shares Outstanding | 74.21 M | ||||
Shares Owned By Insiders | 10.70 % | ||||
Shares Owned By Institutions | 48.58 % | ||||
Number Of Shares Shorted | 259.38 K | ||||
Price To Earning | 1.52 X | ||||
Price To Book | 7.41 X | ||||
Price To Sales | 669.36 X | ||||
Revenue | 701 K | ||||
Gross Profit | 701 K | ||||
EBITDA | (469 K) | ||||
Net Income | (469 K) | ||||
Cash And Equivalents | 46.79 M | ||||
Cash Per Share | 0.63 X | ||||
Debt To Equity | 1.46 % | ||||
Current Ratio | 125.26 X | ||||
Book Value Per Share | 0.04 X | ||||
Cash Flow From Operations | (501 K) | ||||
Short Ratio | 1.71 X | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 14.0 | ||||
Beta | 0.17 | ||||
Market Capitalization | 19.72 M | ||||
Total Asset | 47.75 M | ||||
Retained Earnings | (75.61 M) | ||||
Working Capital | 6.98 M | ||||
Current Asset | 11.78 M | ||||
Current Liabilities | 4.8 M | ||||
Z Score | -1.4 | ||||
Annual Yield | 0.65 % | ||||
Net Asset | 47.75 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Enzon OTC Stock
If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Transaction History View history of all your transactions and understand their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |